Among them, up-stream tyrosine kinase receptor ErbB-2 [28], Rab-like protein 6 (RABL6) [29], microphthalmia-associated transcription factor (MITF) [30], which are involved in progression and development of several types of cancer were predicted to be suppressed (Figure 4B). Here, ERBB2 is linked to cancer.